MetascreenTM Testing platform

MetascreenTM has been using advanced and FDA-approved GC-MS technology combined with proprietary bioinformatics to reliably detect more than 100 metabolic disorders. The laboratory has participated in and passed various external proficiency testing programs from College of American Pathologists and ERNDIM since beginning of 2015.
Want to find out more about MetascreenTM test? download Download Free Infopack